CHPA “Neutral” On Requiring Deadlines For TEA Reviews
This article was originally published in The Rose Sheet
Executive Summary
CHPA comments on the Senate HELP Committee’s draft legislation that would require FDA to establish review deadlines for TEAs. The trade group says it is “neutral” about the proposal, but offers to help the committee with “more comprehensive reviews of OTC approvals.”